SEE
56
6
ADSK
70
2
F
58
11
NWS
66
-3
COF
60
2
WAT
55
2
ACN
52
3
MAS
58
2
CA
38
6
LLY
37
-3
VZ
50
3
ADBE
49
3
CF
57
-2
PEP
48
6
SE
61
-4
PLD
56
8
UPS
60
9
URI
65
5
GS
75
2
CL
58
2
SEE
56
6
ADSK
70
2
F
58
11
NWS
66
-3
COF
60
2
WAT
55
2
ACN
52
3
MAS
58
2
CA
38
6
LLY
37
-3
VZ
50
3
ADBE
49
3
CF
57
-2
PEP
48
6
SE
61
-4
PLD
56
8
UPS
60
9
URI
65
5
GS
75
2
CL
58
2
Financhill
Back

Singular Genomics Systems 10K Form

Buy
69

OMIC
Singular Genomics Systems

Last Price:
21.65
Seasonality Move:
0.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OMIC News And Ratings

See the #1 stock for the next 7 days that we like better than OMIC

OMIC Financial Statistics

Sales & Book Value

Annual Sales: $2.91M
Cash Flow: $-19.8M
Price / Cash Flow: 0
Annual Sales: $49.16
Price / Book: 0.44

Profitability

EPS (TTM): -34.76000
Net Income (TTM): $-86.32M
Gross Margin: $-558K
Return on Equity: -54.24%
Return on Assets: -36.1%

Singular Genomics Systems Earnings Forecast

Key Singular Genomics Systems Financial Ratios

  • The Gross Profit Margin over the past 3 years for OMIC is -19.17%.
  • The Selling, General & Administrative Expenses for OMIC have been equal to 1,871.49% of Gross Profit Margin.
  • The Research & Development expenses have been 1,640.81% of Revenue.
  • The Interest Expense is -1.16% of Operating Income.
  • The Net Earning history of OMIC is -3,257.30% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Singular Genomics Systems Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: OMIC
Website: singulargenomics.com

Debt

Debt-to-Equity Ratio: 0.04
Current Ratio: 7.37
Quick Ratio: 6.52

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OMIC Technical Analysis vs Fundamental Analysis

Buy
69
Singular Genomics Systems (OMIC) is a Buy

Is Singular Genomics Systems a Buy or a Sell?